146 related articles for article (PubMed ID: 16082178)
21. Trichostatin A effectively induces apoptosis in chronic lymphocytic leukemia cells via inhibition of Wnt signaling and histone deacetylation.
Peiffer L; Poll-Wolbeck SJ; Flamme H; Gehrke I; Hallek M; Kreuzer KA
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1283-93. PubMed ID: 24793644
[TBL] [Abstract][Full Text] [Related]
22. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
23. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest.
Yang H; Xu W; Li Y; Lan P; Zhang J; Zhang Y; Zhang C
Anticancer Drugs; 2014 Aug; 25(7):767-77. PubMed ID: 24686006
[TBL] [Abstract][Full Text] [Related]
24. Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C).
Maxhimer JB; Reddy RM; Zuo J; Cole GW; Schrump DS; Nguyen DM
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):53-63. PubMed ID: 15632825
[TBL] [Abstract][Full Text] [Related]
25. Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells.
Joung KE; Kim DK; Sheen YY
Arch Pharm Res; 2004 Jun; 27(6):640-5. PubMed ID: 15283467
[TBL] [Abstract][Full Text] [Related]
26. The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses.
Moreira JM; Scheipers P; Sørensen P
BMC Cancer; 2003 Nov; 3():30. PubMed ID: 14606959
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
[TBL] [Abstract][Full Text] [Related]
28. Sensitization to UV-induced apoptosis by the histone deacetylase inhibitor trichostatin A (TSA).
Kim MS; Baek JH; Chakravarty D; Sidransky D; Carrier F
Exp Cell Res; 2005 May; 306(1):94-102. PubMed ID: 15878336
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of mTOR signalling potentiates the effects of trichostatin A in human gastric cancer cell lines by promoting histone acetylation.
Sun DF; Zhang YJ; Tian XQ; Chen YX; Fang JY
Cell Biol Int; 2014 Jan; 38(1):50-63. PubMed ID: 24030871
[TBL] [Abstract][Full Text] [Related]
30. The histone-deacetylase inhibitor Trichostatin A blocks proliferation and triggers apoptotic programs in hepatoma cells.
Herold C; Ganslmayer M; Ocker M; Hermann M; Geerts A; Hahn EG; Schuppan D
J Hepatol; 2002 Feb; 36(2):233-40. PubMed ID: 11830335
[TBL] [Abstract][Full Text] [Related]
31. KBH-A42, a histone deacetylase inhibitor, inhibits the growth of doxorubicin-resistant leukemia cells expressing P-glycoprotein.
Kang MR; Lee K; Kang JS; Lee CW; Lee KH; Kim JH; Yang JW; Kim BG; Han G; Kang JS; Park SK; Kim HM
Oncol Rep; 2010 Mar; 23(3):801-9. PubMed ID: 20127023
[TBL] [Abstract][Full Text] [Related]
32. A novel histone deacetylase inhibitor, CG0006, induces cell death through both extrinsic and intrinsic apoptotic pathways.
Hwang JJ; Kim YS; Kim MJ; Jang S; Lee JH; Choi J; Ro S; Hyun YL; Lee JS; Kim CS
Anticancer Drugs; 2009 Oct; 20(9):815-21. PubMed ID: 19644355
[TBL] [Abstract][Full Text] [Related]
33. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression.
Siavoshian S; Segain JP; Kornprobst M; Bonnet C; Cherbut C; Galmiche JP; Blottière HM
Gut; 2000 Apr; 46(4):507-14. PubMed ID: 10716680
[TBL] [Abstract][Full Text] [Related]
34. Effect of the histone deacetylase inhibitor trichostatin a in human peripheral blood lymphocytes as a function of donor age.
Sourlingas TG; Kypreou KP; Topakas GN; Karchilaki IN; Stavropoulos-Giokas C; Sekeri-Pataryas KE
Ann N Y Acad Sci; 2007 Nov; 1119():64-71. PubMed ID: 18056955
[TBL] [Abstract][Full Text] [Related]
35. Histone deacetylase inhibitors have a profound antigrowth activity in endometrial cancer cells.
Takai N; Desmond JC; Kumagai T; Gui D; Said JW; Whittaker S; Miyakawa I; Koeffler HP
Clin Cancer Res; 2004 Feb; 10(3):1141-9. PubMed ID: 14871994
[TBL] [Abstract][Full Text] [Related]
36. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells.
Choi YH
Int J Oncol; 2005 Aug; 27(2):473-9. PubMed ID: 16010430
[TBL] [Abstract][Full Text] [Related]
37. Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2-related protein Bad.
Strait KA; Warnick CT; Ford CD; Dabbas B; Hammond EH; Ilstrup SJ
Mol Cancer Ther; 2005 Apr; 4(4):603-11. PubMed ID: 15827334
[TBL] [Abstract][Full Text] [Related]
38. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
[TBL] [Abstract][Full Text] [Related]
39. Modulation of chromatin conformation by the histone deacetylase inhibitor trichostatin A promotes the removal of radiation-induced lesions in ataxia telangiectasia cell lines.
Egidi A; Filippi S; Manganello F; Lopez-Martinez W; Meschini R
Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt A):109-116. PubMed ID: 30389153
[TBL] [Abstract][Full Text] [Related]
40. Radiosensitization by SAHA in experimental colorectal carcinoma models-in vivo effects and relevance of histone acetylation status.
Folkvord S; Ree AH; Furre T; Halvorsen T; Flatmark K
Int J Radiat Oncol Biol Phys; 2009 Jun; 74(2):546-52. PubMed ID: 19427556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]